Ando Takashi, Watanabe Kazuhiro, Mizusawa Takaki, Sakai Takeshi, Katagiri Akiyoshi
Department of Urology, Niigata Prefectural Central Hospital, Shinnancho 205, Jouetsushi, Niigata, 943-0192, Japan.
Department of Pathology, Niigata Prefectural Central Hospital, Shinnancho 205, Jouetsushi, Niigata, 943-0192, Japan.
Urol Case Rep. 2020 Apr 2;31:101155. doi: 10.1016/j.eucr.2020.101155. eCollection 2020 Jul.
Pancreatic metastasis from prostate cancer (PC) is quite rare. Herein, we report the case of a 67-year-old man with pancreatic metastasis from a neuroendocrine differentiated PC (NEDPC), a local recurrence after radical prostatectomy and androgen deprivation therapy for 6 years. Chemoradiotherapy was initiated for the locally recurrent NEDPC, and it had almost disappeared after the therapy. However, rapidly enlarged pancreatic metastasis from the NEDPC was detected 6 months after therapy. There is no standard treatment available for pancreatic metastasis from NEDPC owing to its rarity; hence, further knowledge and clinical experience regarding it are crucial.
前列腺癌(PC)的胰腺转移相当罕见。在此,我们报告一例67岁男性,患有神经内分泌分化型前列腺癌(NEDPC)的胰腺转移,该患者在根治性前列腺切除术后及雄激素剥夺治疗6年后出现局部复发。对局部复发的NEDPC开始进行放化疗,治疗后病灶几乎消失。然而,治疗6个月后检测到NEDPC的胰腺转移灶迅速增大。由于NEDPC的胰腺转移罕见,目前尚无标准治疗方法;因此,关于它的更多知识和临床经验至关重要。